Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Biothera initiates dosing in second arm of trial of Imprime PGG in mCRC

Oct. 20, 2008

Recent patents impart new anticancer agents

Oct. 20, 2008

Cellular assays with vorinostat in combination with conventional chemotherapy for SCLC

Oct. 20, 2008

First-in-class protein kinase D inhibitor shows preclinical anticancer activity

Oct. 20, 2008

FDA grants orphan drug status to Reata's RTA-402 for pancreatic cancer

Oct. 17, 2008

Development of BI-2536 in pancreatic cancer patients not warranted as a result of interim analysis

Oct. 17, 2008

Cleveland BioLabs doses first healthy volunteer in Protectan CBLB-502 study

Oct. 17, 2008

BIBW-2992 evaluated in combination with paclitaxel for solid tumors

Oct. 17, 2008

Evidence of activity seen with CP-751871 in phase I sarcoma study

Oct. 17, 2008

Experiments reveal anticancer mechanisms of CXCR4 antagonists

Oct. 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...